跳至主要内容
临床试验/ACTRN12619000940178
ACTRN12619000940178终止未知

Detection of Mycobacterium avium ssp paratuberculosis (MAP) forms in patients with Crohn’s disease and controls”- a prospective clinical study

Centre for Digestive Diseases0 个研究点目标入组 49 人开始时间: 2019年7月5日最近更新:
适应症

试验速览

阶段
未知
状态
终止
入组人数
49

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
All

入选标准

  • Test group: 40 patients diagnosed with CD or suspected to be diagnosed with CD.
  • Controls: 40 patients (no inflammatory bowel disease, no irritable bowel syndrome, no pathology in the terminal ileum) who are referred to the CDD for a routine colonoscopy due to family history of bowel cancer or polyps or similar reason. These participants are ‘normal’ from the point of view of Crohn’s disease which will be excluded on colonoscopy from examination of the terminal ileum. If a patient in the control group” is diagnosed as having Crohn’s disease in the screening period, the participant will still be included in the test group.
  • Provide written informed consent to participate as shown by a signature on the consent form.

排除标准

  • Consent not obtained.
  • Any contraindications for drug/test – Vaccinated BCG, taking Infliximab or Anti-MAP therapy
  • Clinical evidence of any disease which might interfere with the patient’s ability to enter the trial.
  • Unable to communicate well with the investigators and to comply with the study requirements.

研究者

相似试验